#VisualAbstract: Low plasma ctDNA may be predictive of better survival outcomes in patients with melanoma receiving first-line immune checkpoint inhibitors
Previous Post
Special Report: Vaccines in Development Part 4: Johnson & Johnson vaccine as another frontrunner
Next Post#VisualAbstract CASSIOPEIA Part 1: Bortezomib, Thalidomide, and Dexamethasone with Daratumumab (D-VTd) May Improve Quality of Life Post-Consolidation in Newly Diagnosed, Transplantation-Eligible Multiple Myeloma (MM) Patients
RelatedReports
Popular Reports
Peripherally inserted central catheters are associated with twice as many complications than midline catheters when used short-term
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics Series]
Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer
Ultrasound features associated with shoulder complaints
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.